 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 316 | 回復(fù): 2 | |||
| 當(dāng)前只顯示滿足指定條件的回帖，點(diǎn)擊這里查看本話題的所有回帖 | |||
madai26銀蟲 (小有名氣)
|
[交流]
【求助】有沒有蟲子幫我查一下fasidotril這個藥在國外有沒有上市？ 已有2人參與
|
||
|
因?yàn)槲覀儐挝粵]啥數(shù)據(jù)庫，所以查不到。 fasidotril 法西多曲 ACE/NEP雙向抑制劑 臨床試驗(yàn)做到3期，但后來就沒下文了，哪位好心的蟲子幫個忙呢？幫我把它有沒有上市，在哪上市的查一下？ |
回復(fù)此樓» 猜你喜歡
是否屬于脾腎陽虛證
已經(jīng)有0人回復(fù)
-
藥學(xué)考研調(diào)劑
已經(jīng)有0人回復(fù)
-
藥物學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有147人回復(fù)
-
華南理工大學(xué)-醫(yī)學(xué)院-藥學(xué)專碩少量調(diào)劑名額
已經(jīng)有28人回復(fù)
-
求助《生物利用度和生物等效性研究指導(dǎo)原則》（試 行），2002
已經(jīng)有0人回復(fù)
-
文獻(xiàn)求助
已經(jīng)有0人回復(fù)
-
292藥學(xué)調(diào)劑
已經(jīng)有1人回復(fù)
-
廣西醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院自身免疫病課題組招收基礎(chǔ)醫(yī)學(xué)相關(guān)專業(yè)的調(diào)劑研究生
已經(jīng)有2人回復(fù)
mrzouhao
木蟲之王 (文壇精英)
- DRDEPI: 1
- 應(yīng)助: 179 (高中生)
- 貴賓: 0.108
- 金幣: 100766
- 散金: 11601
- 紅花: 134
- 沙發(fā): 22
- 帖子: 46748
- 在線: 4406.9小時(shí)
- 蟲號: 201350
- 注冊: 2006-02-28
- 專業(yè): 藥劑學(xué)
3樓2010-08-04 15:13:10
nkbeholder
木蟲 (正式寫手)
- DRDEPI: 1
- 應(yīng)助: 11 (小學(xué)生)
- 金幣: 2945.1
- 散金: 4
- 紅花: 5
- 帖子: 748
- 在線: 303.7小時(shí)
- 蟲號: 202353
- 注冊: 2006-03-01
- 性別: GG
- 專業(yè): 藥物化學(xué)
★ ★
madai26(金幣+2):謝謝參與
warlen(金幣+1):謝謝參與 2010-08-04 15:15:09
madai26(金幣+2):謝謝參與
warlen(金幣+1):謝謝參與 2010-08-04 15:15:09
|
這上面寫到2期就中止了。 Originator Company: Bioprojet (France) Parent Company: Bioprojet Licensee: Eli Lilly Highest Phase: Discontinued II Development Status: Discontinued II, France, Congestive heart failure Discontinued II, France, Hypertension Discontinued Preclinical, France, Postmyocardial infarction Introduction: Fasidotril, the prodrug of its active metabolite fasidoprilat, is a mixed inhibitor of ACE and neutral endopeptidase. It was undergoing phase II development with Bioprojet in France for the treatment of congestive heart failure and hypertension. It was also in preclinical development for postmyocardial infarction. However, development appears to have been discontinued. In October 2001, Bioprojet and Eli Lilly announced a development and commercialisation collaboration. Under the terms of the agreement, Lilly received exclusive worldwide commercialisation rights excluding Japan and certain countries in Europe. Lilly was to continue to develop fasidotril through to registration, and was to manufacture the finished product; Bioprojet was to manufacture the bulk material. |
2樓2010-08-04 14:45:13
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 298求調(diào)劑 +3 | 上岸6666@ 2026-03-20 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 化學(xué)調(diào)劑 +3 | yzysaa 2026-03-21 | 3/150 |
|
|
|
[考研] 317求調(diào)劑 +8 | 申子申申 2026-03-19 | 14/700 |
|
|
|
[考研] 297求調(diào)劑 +11 | 戲精丹丹丹 2026-03-17 | 11/550 |
|
|
|
[考研] 一志愿華中科技大學(xué)071000，求調(diào)劑 +3 | 沿岸有貝殼6 2026-03-21 | 3/150 |
|
|
|
[考研] 085700資源與環(huán)境308求調(diào)劑 +12 | 墨墨漠 2026-03-18 | 13/650 |
|
|
|
[考研]
 271材料工程求調(diào)劑
+8
|
.6lL 2026-03-18 | 8/400 |
|
|
|
[考研] 296求調(diào)劑 +6 | www_q 2026-03-18 | 10/500 |
|
|
|
[考研] 一志愿南昌大學(xué)，327分，材料與化工085600 +9 | Ncdx123456 2026-03-19 | 9/450 |
|
|
|
[考研] 304求調(diào)劑 +7 | 司空. 2026-03-18 | 7/350 |
|
|
|
[考研] 材料學(xué)求調(diào)劑 +4 | Stella_Yao 2026-03-20 | 4/200 |
|
|
|
[考研] 353求調(diào)劑 +3 | 拉鉤不許變 2026-03-20 | 3/150 |
|
|
|
[考研] 材料學(xué)碩318求調(diào)劑 +5 | February_Feb 2026-03-19 | 5/250 |
|
|
|
[考研] 一志愿福大288有機(jī)化學(xué)，求調(diào)劑 +3 | 小木蟲200408204 2026-03-18 | 3/150 |
|
|
|
[考研] 085600材料與化工求調(diào)劑 +6 | 緒幸與子 2026-03-17 | 6/300 |
|
|
|
[考研] 本科鄭州大學(xué)物理學(xué)院，一志愿華科070200學(xué)碩，346求調(diào)劑 +4 | 我不是一根蔥 2026-03-18 | 4/200 |
|
|
|
[考研] 【同濟(jì)軟件】軟件（085405）考研求調(diào)劑 +3 | 2026eternal 2026-03-18 | 3/150 |
|
|
|
[考研] 0854可跨調(diào)劑，一作一項(xiàng)核心論文五項(xiàng)專利，省、國級證書40+數(shù)一英一287 +8 | 小李0854 2026-03-16 | 8/400 |
|
|
|
[碩博家園] 湖北工業(yè)大學(xué) 生命科學(xué)與健康學(xué)院-課題組招收2026級食品/生物方向碩士 +3 | 1喜春8 2026-03-17 | 5/250 |
|
|
|
[考研] 070305求調(diào)劑 +3 | mlpqaz03 2026-03-14 | 4/200 |
|